Study reveals lower survival rates for women than men with germ cell tumors

by Uppsala UniversityThe cell of origin, the normal development of sperm and oocytes, and the corresponding tumor development of malignant ovarian and testicular germ cell tumors. Credit:Jo

Updated on: March 20,2024

Study reveals lower survival rates for women than men with germ cell tumors

by Uppsala UniversityThe cell of origin, the normal development of sperm and oocytes, and the corresponding tumor development of malignant ovarian and testicular germ cell tumors. Credit:Jo

Updated on:March 20,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on: March 27,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on:March 27,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on: December 01,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on:December 01,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on: November 10,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on:November 10,2024

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish

Updated on: March 09,2024

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish

Updated on:March 09,2024

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Updated on: January 26,2024

Novel biomarker for immune checkpoint inhibitors identified in human lethal cancers

by Liu Jia,Chinese Academy of SciencesA model depicting how the SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway. Credit: Prof. Wang Yuexi

Updated on:January 26,2024

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on: February 20,2024

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on:February 20,2024

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Updated on: January 11,2024

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Updated on:January 11,2024

The surprising link between circadian disruption and cancer may have to do with temperature

byThe Scripps Research InstituteFor mice placed in ‘chronic jet lag’ (CJL) conditions, they showed a 68% increase in tumor burden when compared to mice placed in 12 hours of light, 12 hours of d

Updated on: January 21,2024

The surprising link between circadian disruption and cancer may have to do with temperature

byThe Scripps Research InstituteFor mice placed in ‘chronic jet lag’ (CJL) conditions, they showed a 68% increase in tumor burden when compared to mice placed in 12 hours of light, 12 hours of d

Updated on:January 21,2024

New therapy strengthens the immune system's counterattack on skin cancer

by Peter Aagaard Brixen, DTU (Technical University of Denmark)Stained electron micrograph of a T cell. Scientists have shown in laboratory experiments that they are able to create a large number of th

Updated on: July 08,2024

New therapy strengthens the immune system's counterattack on skin cancer

by Peter Aagaard Brixen, DTU (Technical University of Denmark)Stained electron micrograph of a T cell. Scientists have shown in laboratory experiments that they are able to create a large number of th

Updated on:July 08,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on: January 26,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on:January 26,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on: January 30,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on:January 30,2024